A head-to-head trial comparing the decades-old steroid, prednisone, and a promising new steroid, vamorolone, finds both act on the same key set of genetic pathways involved in controlling inflammation, indicates a new study. However, the study suggests the new investigational steroid doesn't activate several additional pathways involved in prednisone's bevy of undesirable side effects.
from Top Health News -- ScienceDaily https://ift.tt/2MQvK77
Subscribe to:
Post Comments (Atom)
Omicron has cast a shadow of uncertainty on growth outlook: IndiGo CEO
However, the airline is stronger now when compared to situation in 2020 during the first wave of the pandemic, says Ronojoy Dutta from Com...
-
The Finance Industry Development Council (FIDC) has urged the Ministry of Micro, Small & Medium Enterprises (MSME) to address issues fac...
-
India has started exporting cereals like rice and wheat to new destinations, including Puerto Rico, Yemen and Poland, with a view to push ag...
-
New research links walnut consumption as a contributing factor that could suppress growth and survival of breast cancers. from Top Health ...
No comments:
Post a Comment